The Pennant Group, Inc. (PNTG)
USD 26.06
(-0.53%)
USD 26.06
(-0.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 312.51 Million USD | 0.83% |
| 2022 | 309.93 Million USD | -8.61% |
| 2021 | 339.12 Million USD | 11.23% |
| 2020 | 304.89 Million USD | -5.48% |
| 2019 | 322.57 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 82.17 Million USD | -1.34% |
| 2024 Q1 | 83.29 Million USD | 30.32% |
| 2023 Q3 | 303.35 Million USD | -0.69% |
| 2023 Q4 | 312.51 Million USD | 3.02% |
| 2023 FY | 312.51 Million USD | 0.83% |
| 2023 Q1 | 307.06 Million USD | -0.93% |
| 2023 Q2 | 305.46 Million USD | -0.52% |
| 2022 Q4 | 309.93 Million USD | 1.56% |
| 2022 Q1 | 315.59 Million USD | -6.94% |
| 2022 FY | 309.93 Million USD | -8.61% |
| 2022 Q3 | 305.18 Million USD | 2.5% |
| 2022 Q2 | 297.75 Million USD | -5.65% |
| 2021 Q2 | 329.27 Million USD | 3.15% |
| 2021 FY | 339.12 Million USD | 11.23% |
| 2021 Q4 | 339.12 Million USD | 2.77% |
| 2021 Q3 | 329.98 Million USD | 0.22% |
| 2021 Q1 | 319.22 Million USD | 4.7% |
| 2020 Q1 | 330.93 Million USD | 2.59% |
| 2020 Q2 | 301.26 Million USD | -8.97% |
| 2020 FY | 304.89 Million USD | -5.48% |
| 2020 Q4 | 304.89 Million USD | 2.11% |
| 2020 Q3 | 298.59 Million USD | -0.88% |
| 2019 Q1 | 225.93 Million USD | 0.0% |
| 2019 FY | 322.57 Million USD | 0.0% |
| 2019 Q4 | 322.57 Million USD | 41.86% |
| 2019 Q3 | 227.38 Million USD | 0.41% |
| 2019 Q2 | 226.45 Million USD | 0.23% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 76.723% |
| Addus HomeCare Corporation | 124.13 Million USD | -151.756% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -349.635% |
| Amedisys, Inc. | 346.76 Million USD | 9.878% |
| American Oncology Network, Inc. | 120.44 Million USD | -159.465% |
| Astrana Health, Inc. | 296.26 Million USD | -5.485% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 75.515% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -193.079% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -3266.848% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -11635.261% |
| COMPASS Pathways plc | 28.75 Million USD | -986.727% |
| DocGo Inc. | 15.16 Million USD | -1961.151% |
| The Ensign Group, Inc. | 1.78 Billion USD | 82.491% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -2681.575% |
| InnovAge Holding Corp. | 100.49 Million USD | -210.968% |
| Assure Holdings Corp. | 505 Thousand USD | -61783.168% |
| The Joint Corp. | 2 Million USD | -15525.5% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -11.497% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -81829.221% |
| ModivCare Inc. | 983.75 Million USD | 68.233% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -262559.797% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -17670.234% |
| Option Care Health, Inc. | 1.05 Billion USD | 70.424% |
| P3 Health Partners Inc. | 108.31 Million USD | -188.509% |
| P3 Health Partners Inc. | 108.31 Million USD | -188.509% |
| Surgery Partners, Inc. | 2.03 Billion USD | 84.633% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -259.927% |
| The Oncology Institute, Inc. | 86.82 Million USD | -259.927% |